Researchers will be able to track the brainwaves of animals as they move in natural habitats and interact with each other – complex behaviors that have been impossible to study in the lab.

Cornell researchers have used artificial intelligence to uncover a previously unknown way cells control how proteins move inside them, a process essential for growth, communication and movement, and one that is often disrupted in cancer.

James Balog will discuss his work documenting the world-wide rapid retreat of glaciers on Sept. 17 as part of the visiting professors program.

A Cornell-led research project is developing robots that can perform labor-intensive orchard operations; it’s supported by a four-year, $7.5 million grant from the U.S. Department of Agriculture’s Specialty Crop Research Initiative. 

This discovery could help engineer living materials into different forms, such as the custom of growing bridges from roots in India, and breeding kale so it’s smooth instead of crinkly. 

Edgar Medina Tovar joins the Weill Institute for Cell and Molecular Biology and the College of Arts & Sciences as an assistant research professor in September. He will begin as an assistant professor in January 2027.

Celebrate birds with a fun-filled day of free workshops, presentations, bird walks, and more at the Cornell Lab of Ornithology on Sept. 12 from 10 a.m to 3 p.m.

Folic acid does not elevate toxic formaldehyde in the body, according to a new study on mice and human cancer patients who consumed high doses. 

Diet changes and infection resize an organism’s intestines through different cellular strategies. In malnourished fruit flies, infectious microbes became a source of food, not just a threat.

Seven Cornell research teams have received Center for Advanced Technology grants to advance early-stage life science technologies through collaborations with biotechnology companies across New York state.

The second season of Research Matters, a Cornell video podcast, drops today, with a way-too-relevant episode on why we don't always do the things we know we should.

Cornell researchers successfully ramped up the body’s own immune response to fight melanoma at the tail end of a targeted cancer therapy, when tumors commonly become resistant to these treatments.